BLACK FRIDAY SPECIAL

25% OFF + 1-Yr NT Prime FREE !

Use
00h : 00m : 00s
Claim→
logo

SYNGENE vs TAKE: Stock Comparison

SYNGENE INTERNATIONAL vs TAKEUpdated 20 Nov 26, 4:08 PM ISTNSE & company filings

SYNGENE INTERNATIONAL is the larger company by market capitalisation. SYNGENE INTERNATIONAL shows a higher dividend yield, faster revenue growth and a higher net margin, while TAKE shows a lower P/E, a higher ROE and a higher ROCE. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

SYNGENE leads 8; TAKE leads 4 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

SYNGENETAKE

Valuation lens

What price are you paying?

Market CapContext only
₹18,268 Cr
₹203 Cr
P/E RatioTAKE has the lower reading
97.95x
26.86x ✓
P/B RatioSYNGENE has the lower reading
3.75x ✓
11.13x
EPSSYNGENE has the higher reading
₹0.8 ✓
₹0.15
Book ValueContext only
₹119.88
₹2.1
Dividend YieldSYNGENE has the higher reading
0.28% ✓
0%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
SYNGENE is the larger company
₹18,268 Cr vs ₹203 Cr
P/E Ratio
TAKE has a lower P/E
26.86x vs 97.95x
P/B Ratio
SYNGENE has a lower P/B
3.75x vs 11.13x
EPS
SYNGENE has higher earnings per share
₹0.8 vs ₹0.15
Dividend Yield
SYNGENE has a higher dividend yield
0.28% vs 0%
Revenue Growth (TTM YoY)
SYNGENE has faster revenue growth
1.8% vs 0%
EPS Growth (TTM YoY)
TAKE has faster EPS growth
0% vs -19.5%
Qtr Sales Growth
SYNGENE has stronger quarterly sales growth
13.14% vs -3.15%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricSYNGENETAKE
SectorHealthcare—
IndustryHealthcare Research Analytics & Technology—

Price

MetricSYNGENETAKE
Live Price₹451.7₹13.69
Day Change3.28%4.98%
Volume25.58 L7.57 L
52-Week High₹678.95₹24.39
52-Week Low₹344.45₹9.88
Distance from 52W High-33.47%-43.87%

Valuation

MetricSYNGENETAKE
Market Cap₹18,268 Cr₹203 Cr
P/E Ratio97.95x26.86x
P/B Ratio3.75x11.13x
EPS₹0.8₹0.15
Book Value₹119.88₹2.1
Dividend Yield0.28%0%

Growth

MetricSYNGENETAKE
Revenue Growth (TTM YoY)1.8%0%
EPS Growth (TTM YoY)-19.5%0%
Qtr Sales Growth13.14%-3.15%
Qtr Profit Growth457.78%108.2%

Profitability & Leverage

MetricSYNGENETAKE
ROE6.48%12.68%
ROCE6.92%14.44%
Net Margin11.26%0%
Operating Margin12.3%8.19%
Debt to Equity0x0x

Shareholding

As of Sep 2026 • change vs previous quarter
MetricSYNGENETAKE
Promoter Holding52.59%0%
FII Holding10.14%▼ 1.68 pp0.21%
DII Holding29.3%▲ 1.28 pp0%
Public Holding7.56%▲ 0.42 pp99.79%

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: SYNGENE INTERNATIONAL and TAKE.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.